Metastatic Hormone Refractory Prostate Cancer Completed Phase 1 Trials for Enzalutamide (DB08899)

Also known as: Metastatic hormone refractory Prostate cancer / Metastatic Prostate cancer / Prostate cancer metastatic / Metastatic Prostate Carcinoma / Carcinoma of the prostate metastatic / Prostatic cancer metastatic

IndicationStatusPhase
DBCOND0036371 (Metastatic Hormone Refractory Prostate Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02532114Niclosamide and Enzalutamide in Treating Patients With Castration-Resistant, Metastatic Prostate CancerTreatment